Login / Signup

Capturing Synergy Holistically in Psychedelic Clinical Trials: Assessing Processes in Addition to Outcomes.

Terence H W ChingSarah Shnayder
Published in: Clinical pharmacology and therapeutics (2024)
Keyphrases
  • clinical trial
  • metabolic syndrome
  • open label
  • phase iii
  • double blind
  • glycemic control